PANEL DISCUSSIONPD 05
PD 05 - Value Based Health Care
The Panacea for our Healthcare Woes
Date
Monday, 15th October
Time
11:00-12:30 CEST
09:00-10:30 UTC
Room
Saal 6 - Europe
About the session
What is the issue?
Global healthcare spending has reached an estimated USD 7-8 trillion, a third of which is reported to be “wasted”. The misalignments of incentives, interests, strategies and behaviours of parties engaged in healthcare delivery (i.e. policy makers, regulators, private sector, R&D, providers, suppliers and individuals) are at the core of this inefficiency. Healthcare –in countries where people can benefit from it- is therefore imprecise and inequitable. The misalignments amongst healthcare stakeholders have led to dead ends at the financial (unsustainable costs), human (outcomes far from delivering the expected quality of care) and systemic levels (high degrees of variability between delivery systems).
How can this issue be addressed?
What is known as value-based health care (VBHC) has aimed to redefine how care is organized, measured, and reimbursed. Today, the concept is pushed further with the massive spread of technology, systems and devices allowing for almost real-time evidence-informed strategies and decision-making in healthcare that, in principle, could allow tailoring of care to the needs and differences of each individual and ecosystem.
Global healthcare spending has reached an estimated USD 7-8 trillion, a third of which is reported to be “wasted”. The misalignments of incentives, interests, strategies and behaviours of parties engaged in healthcare delivery (i.e. policy makers, regulators, private sector, R&D, providers, suppliers and individuals) are at the core of this inefficiency. Healthcare –in countries where people can benefit from it- is therefore imprecise and inequitable. The misalignments amongst healthcare stakeholders have led to dead ends at the financial (unsustainable costs), human (outcomes far from delivering the expected quality of care) and systemic levels (high degrees of variability between delivery systems).
How can this issue be addressed?
What is known as value-based health care (VBHC) has aimed to redefine how care is organized, measured, and reimbursed. Today, the concept is pushed further with the massive spread of technology, systems and devices allowing for almost real-time evidence-informed strategies and decision-making in healthcare that, in principle, could allow tailoring of care to the needs and differences of each individual and ecosystem.
Chair(s) / Moderator(s)
Speakers
/445x445/f31c7c91-19f2-478b-ad86-363767c61acd.jpg)
John Amuasi
Kumasi Center for Collaborative Research in tropical Medicine KNUST
Research Group Leader (AG AMUASI)
Ghana
Open
/445x445/c435a9e0-1259-4a0b-9dbc-0e812637e32c.jpg)
Ricardo Baptista Leite
Catholic University of Portugal
Head of Public Health
Portugal
Parliament of Portuguese Republic
Health Committee
Portugal
Open
/445x445/219432cc-5de4-4523-b151-5845ac4fc106.jpg)
Jens Grueger
Roche Pharmaceuticals
Vice President, Head of Global Pricing & Market Access
Switzerland
Open
/445x445/05168c85-c24a-45ee-a197-796590d0b94b.jpg)
Richard Jansen
Medtronic GmbH
Senior Director of Integrated Health Solutions Europe & Russia
Germany
Open
/445x445/3a567fea-172a-4863-923a-75d929ba1b3d.jpg)
Gregory Katz
University Paris Descartes
Chair of Innovation Management & Healthcare Performance
Open
/445x445/54063ea0-88cd-41d6-8f4b-ea3857993db7.jpg)
Nathalie Moll
European Federation of Pharmaceutical Industries and Associations (EFPIA)
Director General
Belgium
Open
/445x445/9d59049b-df58-4a81-930e-096103af42e6.jpg)